NCT03921658View on ClinicalTrials.gov

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Minnesota

OTHER

NCT03921658 - The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer | Biotech Hunter | Biotech Hunter